CSL to lay off up to 15% of workforce, cut R&D costs and spin out vaccine unit Fierce Biotech CSL to Spin Off Seqirus, Cut Up to 15% of Staff in Sweeping Restructure – WSJ The Wall Street Journal CSL Shares Slump as Disappointing Profit Eclipses Spinoff Bloomberg.com CSL shares dive as biotech firm flags more than 3,000 job cuts — as it …
Read More »